OCUL
Ocular Therapeutix Inc
NASDAQ: OCUL · HEALTHCARE · BIOTECHNOLOGY
$9.21
-1.18% today
Updated 2026-04-29
Market cap
$2.00B
P/E ratio
—
P/S ratio
38.59x
EPS (TTM)
$-1.42
Dividend yield
—
52W range
$6 – $16
Volume
4.9M
Ocular Therapeutix Inc (OCUL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.59M | $-12.64M | $-20.50M | $-33.74M | $-34.00M | $-50.47M | $-49.23M | $-77.58M | $-53.55M | $-65.55M | $-59.60M | $-70.23M | $-134.68M | $-204.88M |
| Capital expenditures | $203000.00 | $387000.00 | $1.26M | $1.78M | $1.92M | $8.25M | $1.89M | $2.24M | $841000.00 | $1.19M | $3.71M | $6.09M | $1.29M | $12.01M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $243000.00 | $476000.00 | $2.64M | $4.64M | $5.96M | $7.32M | $7.48M | $8.76M | $7.53M | $14.98M | $16.96M | $17.82M | $33.11M | $43.18M |
| Free cash flow | $-12.79M | $-13.03M | $-21.76M | $-35.52M | $-35.92M | $-58.73M | $-51.12M | $-79.82M | $-54.40M | $-66.74M | $-63.32M | $-76.32M | $-135.97M | $-216.89M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $14.91M | $2.10M | $0.00 | $4.38M | $297000.00 | $37.27M | $747000.00 | $710000.00 | — | $52.57M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $19.89M | $-6.61M | $2.15M | $8.60M | $17.52M | $-4.47M | $173.62M | $-63.89M | $-61.86M | — | — | — |